Pfizer's finance chief Dave Denton is leaving on August 15. Cecile Guegan will be the interim chief financial officer. Denton's departure r...

Global drug companies are boosting U.S. production and stockpiling medicines. This is a response to potential tariffs on branded drugs. Com...

India's drug pricing authority may soon approve a price hike for vital platinum-based cancer medicines. These drugs, including carboplatin ...

Indian equities ended largely unchanged as West Asia tensions tempered risk appetite. Broader markets outperformed despite recent correctio...

The oral drug, pociredir, was being tested ⁠to treat sickle-cell ⁠disease, an inherited blood disorder that can trigger pain, anemia and or...

The study, which followed patients for over five years, found that those ⁠who received ⁠the regimen were nine times more likely to have lit...

Pfizer is prioritizing India for future growth. The company plans to launch new medicines here soon after their global release. Pfizer aims...

A hantavirus outbreak on a cruise ship has sparked public concern. Health officials are working to communicate clearly, drawing lessons fro...

Eli Lilly is making Alzheimer's a major focus for its future innovations. The company is also expanding its specialty medicine offerings in...

Prices for generic semaglutide, a popular weight-loss drug, are expected to fall by more than half in the coming months. This sharp decline...

India’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...

Pfizer reported higher-than-expected sales and profit on Tuesday and said a patent extension for its Vyndamax heart drug and a recent favor...

US stock market surges today: why Dow Jones, S&P 500, and Nasdaq are rallying sharply despite global tensions? The Dow Jones Industrial Ave...

Amazon Web Services anticipates several months to restore cloud operations in Bahrain and the UAE following Iranian drone strikes in early ...

Pfizer has agreed to acquire obesity drug developer Metsera for up to $86.25 a share, surpassing Novo Nordisk's final offer. This move mark...

In a letter written to stockists, distributors and hospitals across India, Pfizer has asked for temporary suspension of sale and distributi...

The recent exit of the world’s largest drug-maker Pfizer Inc’s CFO Alan Levin may have an India angle if the allegations of a US-based blog...